Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients
Tags: HYPERTENSION; CARDIOVASCULAR system -- Diseases; DISEASES -- Risk factors; BLOOD pressure; PATIENTS
Related Articles
- Does the �J-curve� still hold in the post �HOT� era? Grossman, E // Journal of Human Hypertension;Nov98, Vol. 12 Issue 11, p729
Focuses on the J-curve concept that suggests increased cardiovascular risk due to vigorous lowering of blood pressure (BP). Reference to a study conducted to examine the validity of the concept; Comparison of the effect of lowering diastolic BP in diabetic and non-diabetic hypertensive...
- The Influence of a Direct Renin Inhibitor on the Central Blood Pressure. Kubota, Yoshiaki; Takahashi, Hiroshi; Asai, Kuniya; Yasutake, Masahiro; Mizuno, Kyoichi // Journal of Nippon Medical School;2013, Vol. 80 Issue 1, p25
Background: Central blood pressure (CBP) is superior to brachial blood pressure as a predictor of cardiovascular risk in patients with hypertension. There is currently no consensus regarding whether a direct renin inhibitor (DRI) selectively acts on CBP. Methods: Thirty subjects with essential...
- EVALUATION OF HYPERTENSION. // Nurse Practitioners Prescribing Reference;Summer2010, Vol. 17 Issue 2, p5
The article offers information related to the evaluation of hypertension including the classification of blood pressure (BP), the diagnostic workup of the condition, and its identifiable causes. It states that hypertension is a risk factor for major cardiovascular disease (CVD) along with other...
- Adherence: the holy grail of hypertension. // Australian Journal of Pharmacy;Feb2012, Vol. 93 Issue 1101, p30
The article discusses the need to improve adherence rates in patients with hypertension, considered as the deadliest and most common cardiovascular risk factor. It explores the consequences of non-adherence to hypertension medication, and describes tools that can be used by pharmacists in...
- Validaci�n del cuestionario de adherencia al tratamiento anti hipertensivo Mart�n Bayarr� Grau. Mart�nez, Jos� William; Perea, Juli�n Alfonso Villa; Jaramillo, Johana; Betancur, Ana Milena Quintero; Calder�n, Viviana // Revista Medica de Risaralda;2011, Vol. 17 Issue 2, p101
Introduction: The Controls Programmes must reduce cardiovascular risk factors in hypertension patients, but this patients must be monitoring in their behavior and motivation for their care. Objectives: To validate the questionnaire of adherence to antihypertensive treatment. Materials and...
- CRISTOPH -- A cluster-randomised intervention study to optimise the treatment of patients with hypertension in General Practice. Mortsiefer, Achim; Meysen, Tobias; Schumacher, Martin; Lintges, Claudia; Stamer, Maren; Schmacke, Norbert; Wegscheider, Karl; Abholz, Heinz-Harald; In der Schmitten, J�rgen // BMC Family Practice;2008, Vol. 9, Special section p1
Background: Recent guidelines for the management of hypertension focus on treating patients according to their global cardiovascular risk (CVR), rather than strictly keeping blood pressure, or other risk factors, below set limit values. The objective of this study is to compare the effect of a...
- Cardiovascular Risks in a Military Health Care Beneficiary Population with High Blood Pressure. Duong, Diep N.; Smith, Kandy K.; Ross, Candice; Kim, Miyong T. // Military Medicine;Oct2004, Vol. 169 Issue 10, p777
Prevention strategies for coronary artery disease among hypertensive patients require assessment of other modifiable risk factors in the target population. In this article, we describe the prevalence of other cardiovascular risk factors in military beneficiaries with high blood pressure (HBP)....
- Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study. Goudev, Assen; Berrou, Jean-Pascal; Pathak, Atul // Vascular Health & Risk Management;2012 Part 2, Vol. 8, p563
Background: Estimation of total cardiovascular risk is useful for developing preventive strategies for individual patients. The POWER (Physicians' Observational Work on Patient Education According to their Vascular Risk) survey, a 6-month, open-label, multinational, post-marketing observational...
- GP Business: Hypertension - part two. Newson, Louise // GP: General Practitioner;6/21/2004, p49
The latest British Hypertension Society guidelines are similar in many respects to the previous guidelines. They align with European Society guidelines for the classification of hypertension. Mild disease is defined as a blood pressure of 140-159/90-99 mmHg, moderate hypertension as...
